These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 368313)

  • 1. Sodium bromide and sodium valproate: effective suppressants of ethanol withdrawal reactions in mice.
    Goldstein DB
    J Pharmacol Exp Ther; 1979 Feb; 208(2):223-7. PubMed ID: 368313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lorazepam treatment for multiple ethanol withdrawals in mice.
    Becker HC; Veatch LM
    Alcohol Clin Exp Res; 2002 Mar; 26(3):371-80. PubMed ID: 11923591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of ethanol withdrawal symptoms in mice by phenytoin.
    Sprague GL; Craigmill AL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):721-34. PubMed ID: 1034316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative comparison of physical dependence on tertiary butanol and ethanol in mice: correlation with lipid solubility.
    McComb JA; Goldstein DB
    J Pharmacol Exp Ther; 1979 Jan; 208(1):113-7. PubMed ID: 569697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive physical dependence: evidence for a common mechanism in alcohol dependence.
    McComb JA; Goldstein DB
    J Pharmacol Exp Ther; 1979 Jul; 210(1):87-90. PubMed ID: 571913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical aspects of ethanol dependence and withdrawal reactions in mice.
    Chopde CT; Brahmankar DM; Shripad VN
    J Pharmacol Exp Ther; 1977 Feb; 200(2):314-9. PubMed ID: 557109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M; Hinman DJ; Aaronson LM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peak ethanol withdrawal convulsions in genetically selected mice.
    Crabbe JC; Kosobud A; Young ER
    Proc West Pharmacol Soc; 1983; 26():201-4. PubMed ID: 6684291
    [No Abstract]   [Full Text] [Related]  

  • 9. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
    Verleye M; Heulard I; Gillardin JM
    Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol tolerance and withdrawal responses in GABA(A) receptor alpha 6 subunit null allele mice and in inbred C57BL/6J and strain 129/SvJ mice.
    Homanics GE; Le NQ; Kist F; Mihalek R; Hart AR; Quinlan JJ
    Alcohol Clin Exp Res; 1998 Feb; 22(1):259-65. PubMed ID: 9514316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats.
    Fadda F; Colombo G; Mosca E; Gessa GL
    Alcohol Alcohol; 1989; 24(5):447-51. PubMed ID: 2818752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
    Frye GD; McCown TJ; Breese GR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):720-5. PubMed ID: 6310080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dependence on depressant drugs is determined by common genes in mice.
    Crabbe JC; Merrill C; Belknap JK
    J Pharmacol Exp Ther; 1991 May; 257(2):663-7. PubMed ID: 2033513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drinking patterns as predictors of alcohol withdrawal reactions in DBA/2J mice.
    Goldstein DB; Arnold VW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):408-14. PubMed ID: 988179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorazepam and MK-801 effects on behavioral and electrographic indices of alcohol withdrawal sensitization.
    Veatch LM; Becker HC
    Brain Res; 2005 Dec; 1065(1-2):92-106. PubMed ID: 16313888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate in the treatment of the alcohol withdrawal syndrome.
    Lambie DG; Johnson RH; Vijayasenan ME; Whiteside EA
    Aust N Z J Psychiatry; 1980 Sep; 14(3):213-5. PubMed ID: 6783023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of ethanol on pentetrazol-induced seizures and anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice.
    Kleinrok Z; Dziki M; Janczarek T
    Pol J Pharmacol; 1993; 45(4):361-8. PubMed ID: 8118481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium dipropylacetate on the ethanol withdrawal syndrome in rats.
    Le Bourhis B; Aufrere G
    Subst Alcohol Actions Misuse; 1980; 1(5-6):527-35. PubMed ID: 6795731
    [No Abstract]   [Full Text] [Related]  

  • 20. Intranigral muscimol suppresses ethanol withdrawal seizures.
    Gonzalez LP; Hettinger MK
    Brain Res; 1984 Apr; 298(1):163-6. PubMed ID: 6326948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.